[{"_id":"project-settings","settings":{"translateMetaTags":true,"translateAriaLabels":true,"translateTitle":true,"showWidget":true,"isFeedbackEnabled":false,"fv":1,"customWidget":{"theme":"custom","font":"rgb(163, 163, 163)","header":"rgb(255, 255, 255)","background":"rgba(255, 255, 255,0.8)","position":"right","positionVertical":"bottom","border":"rgb(163, 163, 163)","borderRequired":true,"widgetCompact":true,"isWidgetPositionRelative":false},"widgetLanguages":[{"code":"ar","name":"العربية"},{"code":"de","name":"Deutsch"},{"code":"es-LA","name":"Español (América Latina)"},{"code":"fr","name":"Français"},{"code":"it","name":"Italiano"},{"code":"ja","name":"日本語"},{"code":"ko","name":"한국어"},{"code":"pt","name":"Português"},{"code":"zh","name":"中文(简体)"}],"activeLanguages":{"ar":"العربية","de":"Deutsch","es-LA":"Español (América Latina)","fr":"Français","it":"Italiano","ja":"日本語","ko":"한국어","pt":"Português","zh":"中文(简体)","en":"English"},"enabledLanguages":["ar","de","en","es-LA","fr","it","ja","ko","pt","zh"],"debugInfo":false,"displayBranding":true,"displayBrandingName":false,"localizeImages":false,"localizeUrls":false,"localizeImagesLimit":false,"localizeUrlsLimit":false,"localizeAudio":false,"localizeAudioLimit":false,"localizeDates":false,"disabledPages":[],"regexPhrases":[],"allowComplexCssSelectors":false,"blockedClasses":false,"blockedIds":false,"phraseDetection":true,"customDomainSettings":[],"seoSetting":[],"translateSource":false,"overage":false,"detectPhraseFromAllLanguage":false,"googleAnalytics":false,"mixpanel":false,"heap":false,"disableDateLocalization":false,"ignoreCurrencyInTranslation":false,"blockedComplexSelectors":[]},"version":125015},{"_id":"en","source":"en","pluralFn":"return n != 1 ? 1 : 0;","pluralForm":2,"dictionary":{},"version":125015},{"_id":"outdated","outdated":{"#[…] high levels of 2HIB, PGO, DPP, DMP found from an GPL-TOX? What source could all that come from? A: This could all come from water. NAC and <mark ljsid-1=\"\">GSH</mark> will detox all of these except DMP. This has enhanced detox with the addition of pomegranate. Q: What have you found in your experience is the […]":1,"#[…] Pathways The OAT can also offer insight into detoxification processes, which can be influenced by toxic chemical exposure. Pyroglutamic acid is a metabolite that reflects glutathione ( <mark ljsid-1=\"\">GSH</mark>) status, and when elevated, it can indicate insufficient glutathione levels, or a high demand for glutathione.47 Exposures to toxicants, heavy metals, and mycotoxins can influence glutathione […]":1,"#[…] oxidative stress since NAD+ is not supplied (12). When an excess of stress in the mitochondria from increased reactive oxygen species (ROS) becomes too much, glutathione ( <mark ljsid-1=\"\">GSH</mark>) comes in to mitigate the stress. This constant stress eventually depletes <mark ljsid-3=\"\">GSH</mark> as it cannot regenerate fast enough to meet the demand (12). The body then […]":1,"#[…] Q: Do you recommend a biofilm disruptor prior to the Organic Acids Test? A: No Q: Does low pyroglutamic acid (on far left of scale) indicate adequate <mark ljsid-1=\"\">GSH</mark>? A: Yes. The report indicates that low pyroglutamic has no known clinical significance, only high pyroglutamic. Q: How do you treat a fatty acid metabolism […]":1,"#[…] intermediates of styrene) Styrene: Phase I oxidation via CYP2E1 to styrene-7,8-oxide (SO) then by mEH to phenylglyoxylic acid, mandelic acid, and hippuric acid; Phase II glutathione ( <mark ljsid-1=\"\">GSH</mark>) conjugation of SO to form PGO; Ethylbenzene: Mainly CYP2E1 hydroxylation but may go through CYP1A2 and CYP2B6 to a lesser degree. See how the body metabolizes toxins […]":1,"#[…] variety of molds and a significant elevation of this marker could be indicative of an ongoing mold exposure. Q: Do you provoke prior to testing, be it <mark ljsid-1=\"\">GSH</mark>, infrared sauna, etc? Recommendations for provocation protocol? Patients to consider provoking/not provoking? A: We do not recommend provoking for the mycotoxin test. The LC/MS measures the […]":1,"#You searched for Gsh - MosaicDX":1,"#[…] mycotoxins participate in cellular damage during the emergence of complex chronic diseases such as Alzheimer’s. Symptoms that seem specific to mycotoxin-associated Alzheimer’s include a negative Apo-E(4), low <mark ljsid-1=\"\">GSH</mark>, Zn, and triglycerides as well as chronic headache and/or sinusitis. Dr. Bredesen dives deep into the cellular processes underlying the development of Alzheimer’s, emphasizing that the […]":1,"#[…] utilized for the duration of the mold exposure and treatment. Q: Only antifungal treatments for removing mold from lungs and nasal passages? I have heard/seen that nebulized <mark ljsid-1=\"\">GSH</mark> and nasal irrigation with specific sprays gets rid of it. Evan Brand discusses alternatives to antifungals as he got rid of his severe mold infection without using […]":1,"#[…] ATP dependent enzyme 5-oxoprolinase into glutamate. Glutamate is then combined with cysteine via the enzyme gamma-glutamyl cysteine synthetase. The next step is the incorporation of glycine via <mark ljsid-1=\"\">GSH</mark> synthetase to make glutathione itself. Glutathione is then transported out of the cytosol for use throughout the body. For the cycle to continue, reduced glutathione is […]":1,"#[…] Acid (PGO) Yes 1‑10 hours Styrene Phase I: Oxidation via CYP2E1 to form styrene‑7,8‑oxide (SO).18 Then converted by mEH to form phenylglyoxylic acid, mandelic acid, and hippuric acid.7 Styrene Phase II: SO undergoes glutathione ( <mark ljsid-1=\"\">GSH</mark>) conjugation to form PGO.19 Ethylbenzene: Hydroxylation by CYP2E1 mainly, but can also go through CYP1A2 and CYP2B6 to a lesser degree.20 Variability in CYP2E1 activity for […]":1,"#Search Results for: <span ljsid-1=\"\">Gsh</span>":1,"#FONDATEUR DE L'ACADÉMIE DE MÉDECINE INTÉGRATIVE<br ljsid-1=\"\"> Kurt N. Woeller, DO has been an integrative medicine physician and biomedical Autism specialist for over 20+ years. He is an author of several health books including <i ljsid-3=\"\">Autism – The Road To Recovery</i>, <i ljsid-5=\"\">Methyl-B12 Therapy For Autism, Methyl-B12 for Alzheimer’s Disease and Dementia</i>, and <i ljsid-7=\"\">5 Things You MUST Do Right Now To Help With Your Rheumatoid Arthritis</i>. He is an international speaker, educator, and practicing clinician offering specialized interventions for individuals with complex medical conditions. His health consulting practice for Autism alone is multinational with families from various countries. Dr. Woeller serves as a clinical and lab consult for Functional Medicine Clinical Rounds, as well as provides educational seminars for Mosaic Diagnostics (formerly Great Plains Laboratory). He is co-founder of Integrative Medicine Academy (<a ljsid-9=\"\">www.IntegrativeMedicineAcademy.com)</a>, which is an online training academy for health practitioners learning integrative medicine.":1,"#<a ljsid-0=\"\">\"Understanding Neurotransmitter Imbalances from the Organic Acids Test\" by Dr. Woeller</a> depuis <a ljsid-2=\"\">Diagnostic mosaïque</a> on <a ljsid-4=\"\">Viméo</a>.":1,"#Patient Opportunity David, a 2½-year-old patient with neurodevelopmental regression, presented with severe autism, no connection to the environment, and marked aggressiveness. Using MosaicDX’s Organic Acids Test, multiple affected areas were identified, including elevated levels of 4-cresol associated with Clostridium difficile, neurotransmitter alterations, mycotoxins from Aspergillus, elevated levels of arabinose, and oxalates, as well as disruptions […]":1,"#You searched for Methionine+ - MosaicDX":1,"#Search Results for: <span ljsid-1=\"\">Methionine+</span>":1,"#You searched for Same - MosaicDX":1,"#Search Results for: <span ljsid-1=\"\">Same</span>":1,"#[…] of the participants with schizophrenia were vitamin D deficient. Vitamin D deficient participants were 2.16 times more likely to have schizophrenia than vitamin D sufficient participants (Valipour, <mark ljsid-1=\"\">Saneei</mark>, & Esmaillzadeh, 2014). The risk of schizophrenia and vitamin D status vary with season of birth, latitude, and skin pigmentation. The UV rays required to make […]":1,"#You searched for Sane - MosaicDX":1,"#Search Results for: <span ljsid-1=\"\">Sane</span>":1,"#Collection Instructions: Saliva DNA <mark ljsid-1=\"\">méthylation</mark> Pathway Profile Test Kit Contents Start by identifying these elements of your test kit. If you are missing or have expired components, contact Mosaic Customer Service at 800-288-0383. Test kit box Informed Consent Form Four cotton-tipped applicator swabs (in two sleeves) Swab collection return envelope Shipping laboratory pak (or […]":1,"#You searched for Methyl - MosaicDX":1,"#Search Results for: <span ljsid-1=\"\">Methyl</span>":1,"#You searched for comprendre+les+r%C3%A9sultats+des+tests+de+glyphosate - MosaicDX":1,"#Search Results for: <span ljsid-1=\"\">comprendre+les+r%C3%A9sultats+des+tests+de+glyphosate</span>":1,"#« Doc Talk sur la médecine fonctionnelle »":1,"#You can follow Dr. Woeller for ongoing education articles and videos through his <em ljsid-1=\"\">Sous-pile</em> at <a ljsid-3=\"\">https://drwoeller.substack.com/</a> and his <em ljsid-5=\"\">YouTube channel for Integrative Medicine Academy</em> - <a ljsid-7=\"\">https://www.youtube.com/@integrativemedicineacademy</a>. Finally, listen to Dr. Woeller’s latest health professional interviews through his <em ljsid-9=\"\">Doc Talk sur la médecine fonctionnelle</em> Podcast – <a ljsid-11=\"\">https://fonctionnelmedicinedoctalk.com</a>.":1,"#The Enhanced Organic Acids Test (OAT) Report is now available. Check it out here: <a ljsid-1=\"\">العضوية الأحماض اختبار</a>":1,"#<strong ljsid-1=\"\">Test d'acides aminés:</strong> …":1,"#마침내 집중됨":1,"#거식증 에 대한 답변":1,"#그린블랫, MD":1,"#25년 이상의 임상 경험을 바탕으로, 저는 비타민 D 5,000에서 10,000 i.u.를 하루에 한 번 보조 요법으로 사용하여 치료 결과가 크게 개선되는 것을 관찰했습니다.":1,"#정신분열증과 조현병 치료에서 비타민 D 보충제를 분석한 실험은 부족하지만, 이 환자 집단 내에서 비타민 D 수치가 낮은 사람들은 보충제의 혜택을 받는 경향이 있습니다.":1,"#임신 기간 동안 비타민 D 결핍은 조현병과 관련된 뇌 구조에도 영향을 미칠 수 있습니다(Valipour, Sanei, & Esmaillzadeh, 2014).":1,"#그는 또한 정신과 변혁에 전념하는 교육 플랫폼인 Psychiatry Redefined의 설립자이자 정신 질환의 개인화되고 통합적인 치료에 전념하는 전국적 가상 상담 클리닉인 TZ Health의 의료 책임자입니다.":1,"#그린블랫 박사는 2017 년에 정분자 명예의 전당 에 입성했습니다.":1,"#그는 <em ljsid-1=\"\">Answers to Anorexia</em>, <em ljsid-3=\"\">Finally Focused</em>, 그리고 곧 출간될 <em ljsid-5=\"\">항우울제 금단을 위한 기능 및 통합 의학</em> 포함한 7권의 저서를 썼습니다.":1,"#그는 Walden Behavioral Care에서 최고의료책임자로 재직하고 있습니다.":1,"#<strong ljsid-0=\"\"> Greenblatt, MD</strong>, 이중 보드 인증 정신과 의사는 1988년부터 환자를 치료해 왔으며 통합 의학의 선구자입니다.":1,"#영어: 제임스 M.":1,"#As vitamin D levels normalized, symptoms improved.":1,"#From my experience working with individuals with psychosis and schizophrenia in both inpatient and outpatient settings, I have often found low vitamin D levels in this patient population where the severity of symptoms were inversely correlated to serum vitamin D levels.":1,"#도파민은 조현병의 발병 기전에 관여해 왔습니다.":1,"#비타민 D가 정신분열증과 정신분열증에 미치는 영향":1,"#여기에서 확인하세요: <a ljsid-1=\"\">유기산 시험</a>":1,"#강화 유기산 시험(OAT) 보고서가 출시되었습니다.":1,"#고위도에서 피부가 어두운 사람들은 일반 인구보다 조현병에 걸릴 가능성이 더 높은 것으로 추정됩니다(Chiang et al., 2016).":1,"#피부가 가벼운 사람은 멜라닌이 적어 피부가 자외선을 더 효과적으로 흡수할 수 있습니다.":1,"#위도가 높을수록 피부가 어두운 사람은 피부가 밝은 사람보다 비타민 D가 더 뚜렷하게 감소합니다.":1,"#이것은 다시 자외선 가용성 및 이후 비타민 D 상태와 관련이 있을 수 있습니다.":1,"#특히 이민자들 사이에서 고위도 지역에서 조현병 발병률이 증가하는 것으로 나타났습니다.":1,"#따라서 이 신생아들은 산전 및 산전 기간 동안 낮은 수준의 자외선에 노출되었습니다.":1,"#조현병 환자 437,710명을 포함한 한 리뷰에 따르면 대부분의 사람들은 1월과 2월에 태어난 것으로 나타났습니다.":1,"#동물 연구에 따르면 임신 기간 동안 비타민 D 결핍은 도파민 대사에 영향을 미치고 발달 중인 뇌의 도파민 시스템을 변화시킵니다.":1,"#비타민 D를 만드는 데 필요한 자외선은 나중에 조현병을 앓게 되는 사람들의 출생 증가와 가장 관련이 있는 달에 감소합니다.":1,"#조현병과 비타민 D 상태의 위험은 출생 시즌, 위도, 피부 색소 침착에 따라 다릅니다.":1,"#마찬가지로, 뉴질랜드 성인 정신과 입원 환자 102명 중 92%는 비타민 D 수치가 최적이 아니며, 유럽인들보다 10 ng/ml 이하로 심각하게 결핍될 가능성이 두 배 이상 높았습니다 (Menkes et al., 2012).":1,"#태양 노출과 보충제의 영향을 조정한 후 조현병 환자들 사이에서 평균 비타민 D 농도가 대조군(20ng/ml)에 비해 낮은 것으로 나타났습니다(Itzhaky et al., 2012).":1,"#19세에서 65세 사이의 이스라엘 조현병 환자 50명에서 비타민 D 농도가 측정되었습니다.":1,"#비타민 D 보충제를 투여받은 환자들은 결핍을 교정하기 위해 정신병과 우울증 증상이 상당히 개선되었습니다 (Humble et al., 2010).":1,"#중동, 지중해, 동남아시아 또는 아프리카 민족 출신은 저비타민 D의 강력한 예측 인자였습니다.":1,"#조현병과 자폐증이 있는 사람들의 수치가 가장 낮았습니다.":1,"#117명의 정신과 환자 중 85% 이상이 비타민 D 수치가 최적이 아니었습니다.":1,"#스웨덴 연구원들은 비타민 D 결핍의 가능한 예측 인자를 확인하기 위해 정신과 외래 진료에서 의료 차트를 검토했습니다.":1,"#비타민 D는 조현병과 관련된 경로에 관여하는 많은 유전자의 전사를 조절합니다. 여기에는 시냅스 가소성, 신경 발달, 산화 스트레스에 대한 보호에 관여하는 유전자가 포함됩니다(Graham et al., 2015).":1,"#메커니즘은 명확하지 않지만, 최근 연구에 따르면 비타민 D의 염증 및 면역 과정 조절 작용이 조현병 환자의 임상 증상 발현과 치료 반응에 영향을 미칠 가능성이 높다고 합니다(Chiang, Natarajan, & Fan, 2016).":1,"#비타민 D 수치가 정상화되면서 증상이 개선되었습니다.":1,"#가장 최근에는 조현병, 정신병, 선택적 돌연변이, 양극성 장애를 가진 사람들을 대상으로 한 실험실 검사에서 혈청 비타민 D 수치가 20 ng/ml 이하로 일관되게 나타났습니다.":1,"#입원 환자와 외래 환자 모두에서 정신분열증과 조현병을 앓고 있는 사람들과 함께 일한 경험을 통해, 저는 종종 이 환자 집단에서 증상의 심각도가 혈청 비타민 D 수치와 반비례하는 낮은 비타민 D 수치를 발견했습니다.":1,"#비타민 D 결핍은 다양한 주요 정신 질환과 관련이 있으며 연구자들에게 새롭게 떠오르는 관심 분야입니다.":1,"#비타민 D 결핍 참가자는 비타민 D 결핍 참가자보다 조현병에 걸릴 확률이 2.16배 더 높았습니다(Valipour, Sanei, & Esmaillzadeh, 2014).":1,"#이 연구의 2,804명의 참가자 중 65% 이상의 조현병 환자가 비타민 D가 결핍되어 있었습니다.":1,"#1988년부터 2013년까지 발표된 19개의 연구를 검토한 한 메타 분석에서는 비타민 D 결핍과 조현병 사이에 강한 연관성이 있음을 발견했습니다.":1,"#비타민 D 결핍과 조현병 발병 사이의 연관성은 전 세계 모든 연령대의 환자들 사이에서 연구되었습니다.":1,"#비타민 D 수치가 낮을수록 전반적인 인지 결손이 더 심각해지는 것으로 나타났습니다(Graham et al., 2015).":1,"#따라서 항염증 메커니즘이 있을 수 있습니다(Chiang et al., 2016).":1,"#부정적인 증상의 심각도가 높을수록(무뎌진 감정, 감정적 위축, 나쁜 친밀감, 수동적이고 무관심한 사회적 위축, 추상적인 사고, 고정관념적인 사고) 비타민 D 수치가 낮아지는 것과 강하게 상관관계가 있었습니다.":1,"#비타민 D는 첫 번째 조현병 환자 20명을 대상으로 분석되었습니다.":1,"#두 번째 연구는 이 결과를 뒷받침합니다.":1,"#비타민 D 결핍이 있는 사람들은 환각, 편집증 또는 망상을 겪을 가능성이 3.5배 더 높았습니다(Grassive et al., 2012).":1,"#비타민 D 상태는 정신 질환의 중증도와 관련이 있었습니다.":1,"#평가된 104명의 환자 중 72%가 비타민 D 수치가 불충분했습니다.":1,"#입원 또는 부분 입원이 필요한 12~18세 정신질환 청소년을 대상으로 단면 분석을 실시했습니다.":1,"#비타민 D 결핍은 더 심각한 증상과 관련이 있습니다.":1,"#비타민 D 보충제를 정기적으로 복용한 남성은 보충제를 복용하지 않은 남성에 비해 조현병 위험이 88% 감소했습니다(맥그래스 외, 2004).":1,"#그들은 핀란드 출생 코호트를 조사하여 유아기 동안 비타민 D 보충제의 빈도와 용량에 대한 데이터를 수집했습니다.":1,"#비타민 D가 낮은 세포는 높은 수준의 염증성 사이토카인을 생성하는 반면, 비타민 D가 충분한 세포는 이러한 사이토카인을 훨씬 적게 방출합니다.":1,"#같은 연구 그룹은 생후 첫해에 비타민 D 보충제를 복용하는 것이 남성의 조현병 위험 감소와 관련이 있다는 사실도 발견했습니다.":1,"#연구자들은 이 모든 신생아들이 최적의 비타민 D 수치를 가지고 있었다면, 조현병 사례의 40% 이상을 피할 수 있었을 것이라고 추정했습니다.":1,"#그들은 또한 신생아 비타민 D 농도가 낮은 사람들이 조현병 위험이 증가한다는 사실을 발견했습니다.":1,"#놀랍지 않게도 그들은 덴마크로 이주한 어머니들의 자손에서 비타민 D 상태의 계절적 변화와 비타민 D 수치가 현저히 낮다는 것을 발견했습니다.":1,"#그들은 덴마크 정신과 중앙 등록부에서 조현병 환자 424명을 식별하고 신생아 건조 혈흔을 분석했습니다.":1,"#McGrath et al. (2010)은 신생아 비타민 D 상태와 이후 조현병 위험 간의 관계를 조사했습니다.":1,"#정신병적 경험이 조현병 발병과 관련이 있다면, 이는 비타민 D 농도가 높은 경우 조현병과 보호적 연관성이 있을 수 있음을 뒷받침합니다(톨파넨 외, 2012).":1,"#어린 시절의 비타민 D 농도는 초기 청소년기의 정신병적 경험과 관련이 있었습니다.":1,"#영국에서 3,182명의 어린이로 구성된 예비 출생 코호트에서 연구자들은 9.8세의 비타민 D 수치를 측정하고 12.8세의 정신병적 경험을 평가했습니다.":1,"#혈청 비타민 D 수치는 최적의 수치에 도달할 때까지 매 두 달마다 재평가되어야 합니다.":1,"#조현병 환자들은 일반적으로 염증 지표가 높습니다.":1,"#이 영양-질병 관계의 근본적인 메커니즘은 추측할 수 있을 뿐입니다.":1,"#IgE食物过敏基础测试":1,"#紫色和灰色的IgE霉菌过敏测试标志-MosaicDX":1,"#IgE模具":1,"#欧米茄-3指数完整":1,"#氨基酸测试尿液随机":1,"#带有白色背景的蓝色和灰色念珠菌+酵母标志的IgG食品地图-MosaicDX":1,"#秒表的图形图标，说明MosaicDX的解决方案有多快和方便 - MosaicDX":1,"#揭示完整画面":1,"#切换菜单":1,"#激素综合小组":1,"#激素综合加小组":1,"#综合大便分析":1,"#OAT（有机酸测试）的描述性图像-MoaicDX":1,"#有机酸测试（OAT）101：OAT新手的基本信息":1,"#马赛克诊断 | 揭示完整画面":1,"#从业人员登录":1,"#分销商登录":1,"#领英公司":1,"#搜索...":1,"#You searched for 24-hour+urinary+amino+acids - MosaicDX":1,"#Search Results for: <span ljsid-1=\"\">24-hour+urinary+amino+acids</span>":1,"#You searched for Urine+ - Page 3 of 13 - MosaicDX":1,"#You searched for Urine+ - Page 2 of 13 - MosaicDX":1,"#[…] Organic Acids Test (OAT): Organic acids are acidic byproducts of cellular metabolism that are produced by living organisms… View Test Metabolic Assessment Microbial Organic Acids Test ( <mark ljsid-1=\"\">MOAT</mark>): Organic acids are substances that result from the metabolic processes in your body. View Test Background Theo is a 5-year-old male with an Autism-Spectrum diagnosis who […]":1,"#[…] not discontinue medications or supplements without first consulting your healthcare practitioner. Test Requirements Test Requirements / Notes Organic Acids Test (OAT) and Microbial Organic Acids Test ( <mark ljsid-1=\"\">MOAT</mark>) Minimum 10 mL. For 48 hours before collection avoid apples, grapes, raisins, pears, cranberries, and their juices/products; also avoid arabinogalactan, echinacea, reishi mushrooms, and ribose supplements. […]":1,"#[…] test. Important: Do not discontinue any medications or supplements without first consulting your healthcare practitioner. Test Requirements Organic Acids Test (OAT) and Microbial Organic Acids Test ( <mark ljsid-1=\"\">MOAT</mark>) For 48 hours before collection: avoid apples, grapes, raisins, pears, cranberries, and their juices or products. Also avoid arabinogalactan, echinacea, reishi mushrooms, and ribose supplements. Wait […]":1,"#American Samoa":1,"#Collection Instructions: <mark ljsid-1=\"\">Cabello</mark> – Metals Toxic + Nutrient Elements Test Kit Contents Start by identifying these elements of your test kit. If you are missing or have expired components, contact Mosaic Customer Service at 800-288-0383. Test kit box or envelope Clear zip-lock bag Cardboard <mark ljsid-3=\"\">pelo</mark> scale Return shipment envelope Before You Start If you […]":1,"#<mark ljsid-0=\"\">Cabello</mark> Sample Collection Instructions":1,"#[…] India and Australia only) Please list MosaicDX as the “consignee,” indicate that the sample is for “lab research/human non-infectious,” and specify the type of sample (i.e., urine, <mark ljsid-1=\"\">pelo</mark>, stool, etc.) On the second page, you should enter your information as “declarant.” This includes your name, contact information, and email address as directed. Example Declaration […]":1,"#[…] and interfere with its functioning. These toxic metals have no known physiological functions and can cause harm to organ systems. MosaicDX offers various testing options, including urine, blood, stool, and <mark ljsid-1=\"\">pelo</mark> samples, to evaluate the status of toxic metals and essential elements. This allows practitioners to select the most clinically appropriate option for their patients.":1,"#[…] its functioning. These toxic metals have no known physiological functions and can cause harm to organ systems. MosaicDX offers various testing options, including urine, blood, stool, and <mark ljsid-1=\"\">pelo</mark> samples, to evaluate the status of toxic metals and essential elements. This allows practitioners to select the most clinically appropriate option for their patients. Our high-complexity […]":1,"#MosaicDX offers a number of options for assessing nutrient and toxic (heavy metals) elements, these include urine, <mark ljsid-1=\"\">pelo</mark>, stool, whole blood and red blood cell. Heavy metals can be toxic to organ systems when they accumulate in the body and may disrupt the balance of essential nutrients. A number of variables impact which sample type […]":1,"#Search Results for: <span ljsid-1=\"\">pelo</span>":1,"#Scarica il PDF qui":1,"#[…] acids are acidic byproducts of cellular metabolism that are produced by living organisms… View Test Metabolic Assessment Amino Acids Test: … View Test Metabolic Assessment Omega-3 Index <mark ljsid-1=\"\">Complete</mark>: While traditionally the health impact of fatty acids was mainly associated with cardiovascular d… View Test View All Tests Lyme + Co-Infections Lyme + Co-Infections Lyme […]":1,"#You searched for Evirotox+complete - MosaicDX":1,"#Omega-3 Index <mark ljsid-1=\"\">Complete</mark>":1,"#Omega-3 Index <mark ljsid-1=\"\">Complete</mark> Sample Test Report":1,"#Simply <mark ljsid-1=\"\">complete</mark> the form and a member of our customer service team will be in touch within two business days with nearby practitioner information. Notice: JavaScript is required for this content.":1,"#[…] IgG Food MAP with Candida + Yeast Dried Blood Spot (DBS) = SDS DBS Mfg catalog AND SDS Lancets Serum = SDS Serum kit Metals – Toxic + Nutrient Stool SDS Stool kit MCC Total Fix 2805-05 (Yellow top vial) Microbiology Test SDS Microbiology Profile Omega 3 Index <mark ljsid-1=\"\">Complete</mark> SDS DBS Mfg catalog AND SDS Lancets Streptococcus Antibodies Profile SDS Serum kit Vitamin D Test SDS DBS Mfg catalog AND SDS Lancets OR SDS Serum kit":1,"#Showing results for <em ljsid-1=\"\">efforts complete</em>":1,"#Search Results for: <span ljsid-1=\"\">Evirotox+complete</span>":1,"#<span ljsid-0=\"\">25年以上</span>先駆的な機能性医学検査。":1,"#<strong ljsid-0=\"\">ここからダウンロードできます</strong>。":1,"#<strong ljsid-0=\"\">はこちらからダウンロードできます</strong>。":1,"#はこちらからダウンロードできます":1,"#Form submitted successfully.\nA confirmation email was sent to alex_eagr@hotmail.com.":1,"#A confirmation email was sent to alex_eagr@hotmail.com.":1,"#MycoTOX个人资料™":1,"#Ensure the vials are labeled and tightly sealed.":1,"#Put on a glove and collect stool sample in the collection tray. Do not allow urine or water to touch the sample.":1,"#Complete the information on the barcode sticker <strong ljsid-1=\"\">AND</strong> the vials by writing the patient name, date of birth, and collection date. Place the barcode stickers on the vials, ensuring information written on the vials is visible. Use blue or black ink from a ball-point pen. Do not use felt-tipped pens or dry-erase markers. <strong ljsid-3=\"\">Note: Unlabeled samples will be rejected.</strong>":1,"#Collection Instructions:<br ljsid-1=\"\"> GI360™ Essentials Profile":1,"#December 12, 2025":1,"#Dawn Franzmeier":1,"#GI360 Essentials Stool Collection Instructions Collection Instructions: GI360™ Essentials Profile Test Kit Contents Start by identifying these elements of your test kit. If you are missing or have":1,"#GI360 Essentials Stool Collection Instructions - MosaicDX":1,"#Samples must be shipped on <strong ljsid-1=\"\">Monday, Tuesday, or Wednesday</strong> (outside the U.S., Monday or Tuesday). If you collect on the weekend, hold the specimen until Monday to ship.":1,"#Place the yellow-top and black-top vials into the plastic biohazard bag. Add the absorbent packing sheet and seal.":1,"#Complete the information on the barcode sticker <strong ljsid-1=\"\">Y</strong> the vials by writing the patient name, date of birth, and collection date. Place the barcode stickers on the vials, ensuring the information written on the vials is visible. Use blue or black ink from a ball-point pen. Do not use felt-tipped pens or dry-erase markers. <strong ljsid-3=\"\">Note: Unlabeled samples will be rejected.</strong>":1,"#Black Tops (3)":1,"#Or":1,"#Find a T":1,"#Explore our Metals – Toxic + Nutrient Elements – Whole Blood Resources":1,"#Arsenic<br ljsid-1=\"\"> Barium<br ljsid-3=\"\"> Cadmium<br ljsid-5=\"\"> Cobalt<br ljsid-7=\"\"> Lead<br ljsid-9=\"\"> Mercury<br ljsid-11=\"\"> Nickel<br ljsid-13=\"\"> Platinum<br ljsid-15=\"\"> Thallium<br ljsid-17=\"\"> Tungsten<br ljsid-19=\"\"> Uranium":1,"#Calcium<br ljsid-1=\"\"> Copper<br ljsid-3=\"\"> Lithium<br ljsid-5=\"\"> Magnesium<br ljsid-7=\"\"> Manganese<br ljsid-9=\"\"> Molybdenum<br ljsid-11=\"\"> Selenium<br ljsid-13=\"\"> Strontium<br ljsid-15=\"\"> Zinc<br ljsid-17=\"\"> Vanadium (V)<br ljsid-19=\"\"> Chromium (Cr)":1,"#do Perfil TOXDetect":1,"#Teste de Ácidos Orgânicos (OAT":1,"#metais – nutrientes + elementos tóxicos":1,"#You can follow Dr. Woeller for ongoing educational articles and videos through his <em ljsid-1=\"\">Subpilha</em> at <a ljsid-3=\"\">https://drwoeller.substack.com/</a> and his <em ljsid-5=\"\">YouTube channel for Integrative Medicine Academy</em> – <a ljsid-7=\"\">https://www.youtube.com/@integrativemedicineacademy</a>. Finally, listen to Dr. Woeller’s latest health professional interviews through his <em ljsid-9=\"\">Palestra Doc sobre Medicina Funcional</em> Podcast – <a ljsid-11=\"\">https://funcionalmedicinedoctalk.com</a>.":1,"#Because of the immunosuppressive abilities of mycotoxins released from <em ljsid-1=\"\">アスペルギルス </em>and other colonizing mold species, <em ljsid-3=\"\"> </em>can frequently coinfect a patient.<sup ljsid-5=\"\">23</sup> Species of <em ljsid-7=\"\"> </em>are frequently opportunistic pathogens that may cause various infections from oral candidiasis to systemic blood stream infections.<sup ljsid-9=\"\">24</sup> There are over 200 species of invasive <em ljsid-11=\"\">Candida. Candida </em>albicans is the most prevalent fungal pathogen of humans, however <em ljsid-13=\"\">Candida glabrata</em>, <em ljsid-15=\"\">Candida krusei</em>, <em ljsid-17=\"\">Candida tropicalis</em>、および <em ljsid-19=\"\">Candida parapsilosis </em>can also cause human candidiasis.<sup ljsid-21=\"\">25</sup> <em ljsid-23=\"\"> </em>can colonize skin, mucosal surfaces, and the gastrointestinal tract. As a marker for <em ljsid-25=\"\"> </em>colonization, we measured citramalic acid, which has been shown to be produced by various species of yeast.<sup ljsid-27=\"\">26</sup>":1,"#Studies have shown that multiple species of mold can colonize different tissues in the body including the lungs, gastrointestinal tract, and sinus cavities and a recent study found <em ljsid-1=\"\">アスペルギルス </em>and <em ljsid-3=\"\">ペニシリウム </em>species to be present in the gastrointestinal tracts of healthy volunteers.<sup ljsid-5=\"\">19</sup> Some of the most frequently diagnosed fungal pathogens come from the genera <em ljsid-7=\"\">アスペルギルス </em>and <em ljsid-9=\"\"> </em>. To test for colonization of <em ljsid-11=\"\">Aspergillus, </em>we measured 5-hydroxymethyl-2-furoic and furan-2,5-dicarboxylic acids.<sup ljsid-13=\"\">20-21</sup> We measured tricarballylic to indicate the presence of<em ljsid-15=\"\">フザリウム </em>species.<sup ljsid-17=\"\">22</sup>":1,"#Monitoring mycotoxins and their metabolites in human samples to assess the exposure of individuals to mold is one of the first steps in determining the proper treatment for these patients. Recent advances in LC-MS/MS techniques now allow urinary biomarker assessments at environmentally relevant concentrations.10,15-17 Studies have shown that mycotoxins are produced by multiple species of mold, including those from <em ljsid-1=\"\">Stachybotrys, Aspergillus, Fusarium, and Penicillium</em><sup ljsid-2=\"\">9</sup><em ljsid-3=\"\"> </em>genera. Some of the important mycotoxins produced by these molds include aflatoxin M1 (AFM1) and ochratoxin A (OTA) from <em ljsid-5=\"\">アスペルギルス </em>and <em ljsid-7=\"\">ペニシリウム</em>, zearalenone (ZEA) and enniatin B (ENB) from <em ljsid-9=\"\">フザリウム</em>, sterigmatocystin (STC) from <em ljsid-11=\"\">ペニシリウム</em>, roridin E (ROE) and verrucarin A (VER) from <em ljsid-13=\"\">スタキボトリス</em>).<sup ljsid-15=\"\">15</sup> Urine has been determined to be the preferred matrix for mycotoxin analysis because most mycotoxins are metabolized and excreted via urine.<sup ljsid-17=\"\">18</sup>":1,"#Patients that were exposed to mold also had a higher instance of yeast colonization, which was measured by increased levels of the yeast metabolite citramalic. The mitochondrial marker lactic acid was significantly elevated in patients exposed to mold. Oxalic acid, a toxic metabolite of <em ljsid-1=\"\">アスペルギルス</em>, was elevated in the patients who were colonized. Oxalic acid has been shown to have toxic effects on virtually every organ of the human body including urinary tract, cardiovascular system, brain, muscles, thyroid gland, and eyes.<sup ljsid-3=\"\">44</sup> Lastly, pyroglutamic, a glutathione usage deficiency marker, was elevated in the patients exposed to mold versus our control samples. This was expected because glutathione is depleted in the detoxification of many mycotoxins.":1,"#For biomarker analysis by GC/MS, there were several significant differences between the exposed group versus the control group (Table 2). The <em ljsid-1=\"\">アスペルギルス </em>and <em ljsid-3=\"\">フザリウム </em>markers 5-hydroxymethyl-2-furioc, furan-2,5-dicarboxylic, and tricarballylic acids were all significantly elevated in patients with mold exposure. A previous study indicated that one site of mold colonization was the gastrointestinal tract that was ascertained by treatment with the antifungal drug nystatin, which is not absorbed from the gastrointestinal tract. The fact that the mold markers in that study were significantly reduced (56-63%) after 10 days of nystatin indicated that at least a substantial portion of the molds producing these markers was from the gastrointestinal tract.<sup ljsid-5=\"\">43</sup> The fact that the gastrointestinal tract was colonized with mold species also indicates that patients exposed to mold that has colonized the gastrointestinal tract might continue to have severe symptoms long after moving out of a mold-contaminated environment unless treated with antifungal agents to kill gastrointestinal molds.":1,"#<em ljsid-0=\"\"> </em>as well as other pathogens can infect a patient that has been exposed to mycotoxins.<sup ljsid-2=\"\">23</sup> One reason for this increased risk of infection is that many mycotoxins possess immunosuppressive affects.<sup ljsid-4=\"\">41</sup> To measure the amount of <em ljsid-6=\"\"> </em>residing in a patient, we selected citramalic as a marker, which has been shown to be produced by multiple strains of yeast (Figure 5).<sup ljsid-8=\"\">26</sup> Citramalic was significantly higher in the mold-exposed group versus the control group (1.45 vs 1.02 mmol/mol of creatinine) (p value = 0.00191).":1,"#To determine if markers for <em ljsid-1=\"\">アスペルギルス </em>or <em ljsid-3=\"\">フザリウム </em>growth is more abundant in patients exposed to mycotoxins vs controls, we decided to measure the amounts of three different markers. Two metabolites, 5-hydroxymethyl-2-furoic and furan- 2,5-dicarboxylic acids, were analyzed as markers for <em ljsid-5=\"\">アスペルギルス </em>(Figure 2) and tricarballylic measurements were used as an indicator for <em ljsid-7=\"\">フザリウム </em>(Figure 3). The 5-hydroxymethyl-2-furoic acid values were higher in patients exposed to mold vs the control patients (9.11 vs 2.91 mmol/mol of creatinine) (p value= 0.00075). Furan 2,5-dicarboxylic acid was also found to be higher in patients exposed to mold. In the mold-exposed patients, furan-2,5-dicarboxylic acid was 8.23 and in the control group it was 4.32 ng/g creatinine (p value = 0.00904). The tricarballylic acid mean was found to be twice as much in the mold-exposed group versus the control group (0.46 vs 0.22 mmol/mol of creatinine) (p value = 0.0493). One additional marker that we measured was oxalic acid. Oxalic acid is a biproduct from <em ljsid-9=\"\">Aspergillus.</em><sup ljsid-10=\"\">40</sup> Oxalic acid in the colonized group was significantly higher than the control group (Figure 4) (137.7 vs 72.6 mmol/mol of creatinine) (p value=0.0029).":1,"#Mycotoxin exposure can affect many different systems in the body. Measurements of these effects on patients can help in treatment. Utilizing GC/MS, we measured other markers that could be altered by exposure to mycotoxins. The markers that we were most interested in testing were related to <em ljsid-1=\"\">アスペルギルス </em>colonization, yeast colonization, mitochondrial status, and glutathione status.":1,"#Seven different mycotoxins, including aflatoxin M1, ochratoxin A, sterigmatocystin, zearalenone, roridin E, verrucarin A, and enniatin B1 that have been associated with human illness were tested by LC/MS/ MS in urine samples of a control group of 89 healthy adult volunteers and 103 adult patients suspected of mold illness based on clinical symptoms assessed by their physicians and findings of mold growth in their homes or offices. In addition, markers of gastrointestinal mold and yeast colonization, mitochondrial function, and glutathione status markers were assessed in the same urine samples by GC/MS. Values for all the mycotoxins tested were significantly increased in the mold patient group compared to the control group. Markers for mold colonization of the gastrointestinal tract were all significantly more elevated in the mold-exposed group compared to the control group. Lactic acid, oxalic acid, and pyroglutamic acid were all significantly higher in the mold- exposed patient group compared to the control group. Succinic acid, a marker of mitochondrial function was also higher in the mold- exposed group but did not reach statistical significance. Elevated markers of <em ljsid-1=\"\">フザリウム </em>and <em ljsid-3=\"\">アスペルギルス </em>gastrointestinal colonization in mold- exposed patients indicates a need for antifungal treatment for successful treatment of mold-exposed patients.":1,"#Scott Mattivi, CEO of Mosaic Diagnostics,":1,"#Celebrate our shared mission to empower practitioners through science-driven insights.":1,"#Hear directly from MosaicDX leadership about their vision for 2026 and beyond.":1,"#Learn how clinical education and testing advancements are shaping patient care.":1,"#Reflect on MosaicDX’s 2025 highlights, growth, and innovation.":1,"#Key Takeaways:":1,"#Together, they’ll revisit this year’s key accomplishments from new educational initiatives and test innovations to expanded global partnerships and practitioner success stories. You’ll also gain insight into what’s ahead for 2026, including upcoming clinical education, research, and resources designed to help practitioners improve patient outcomes through comprehensive diagnostic testing.":1,"#2025 Highlights: A Year in Review with MosaicDX Leadership - MosaicDX":1,"#Join Mosaic Diagnostics for a special year-end webinar reflecting on the milestones, progress, and partnerships that defined 2025. Hosted by <strong ljsid-1=\"\">Scott Mattivi, CEO</strong>, alongside <strong ljsid-3=\"\">Kurt Woeller, DO, Chief Medical Officer</strong>, and <strong ljsid-5=\"\">Michelle Maddux, ND</strong>, this discussion will highlight MosaicDX’s continued commitment to advancing functional and integrative medicine worldwide.":1,"#Originally from Pittsburg, Kansas, Scott holds a degree in Biology from Pittsburg State University, and a Medical Technology degree from the University of Kansas. When not at Mosaic’s headquarters in Kansas, Scott resides in Colorado Springs. He is a devoted husband, father of two grown children, and proud grandfather. Scott’s passions include his faith, his family, the dedicated teams he leads, and the mission of supporting the practitioners who work tirelessly to improve the lives of patients navigating complex, chronic disease.":1,"#, where he spent more than 22 years driving growth across various roles.":1,"#Quest Diagnostics":1,"#including President, Vice-President of Operations, and General Manager. He began his career in laboratory management at":1,"#Eurofins Viracor BioPharma Services,":1,"#and spent over a decade in progressive leadership positions at":1,"#Pathology Watch":1,"#is a visionary leader in the diagnostic laboratory space with nearly 40 years of experience spanning clinical, biopharma, and laboratory operations. Before joining MosaicDX, Scott held executive roles overseeing clinical labs and biopharma/clinical trial services. He most recently served as Chief Operating Officer at":1,"#December 1, 2025":1,"#Register for the January 14th Webinar Here":1,"#<strong ljsid-0=\"\">Prueba de aminoácidos:</strong> …":1,"#Functional and integrative medicine licensed practitioners who are new to the category, and/or new or experienced with MosaicDX testing and/or those who want to dive deeper.":1,"#Who Should Attend?":1,"#Dates<br ljsid-1=\"\"> & Location":1,"#Deepening Clinical Expertise. Elevating Clinical Impact. Driving the Future of Functional Medicine, Together. Introducing the EDGE Summit, from Mosaic":1,"#This two-day immersive educational event blends cutting-edge instruction on MosaicDX’s leading profiles with real-world case studies, ensuring participants leave not only inspired, but fully equipped with actionable insights they can immediately apply in clinical practice.":1,"#EDGE Summit 2026 - MosaicDX":1,"#EDGE Summit audience and laboratory scenes":1,"#Practice Growth Guidance icon":1,"#Real-World Case Expertise icon":1,"#Evidence-Based Interventions icon":1,"#Master the Complex Case icon":1,"#Mastering the Organic Acids Test icon":1,"#Michelle Maddux, N.D.":1,"#Teresa McBride, N.D.":1,"#EDUCATION DESIGNED FOR GREATER EXPERTISE.":1,"#EDGE Summit by Mosaic Diagnostics":1,"#and step into the future of care, where Education Designed for Greater Expertise, empowers you to lead with confidence, innovate with purpose, and advance clinical excellence.":1,"#Join us at the":1,"#LET US KNOW IF YOU ARE INTERESTED IN THE EVENT":1,"#Fill out the form by clicking the link below to be the first on the list to learn more about The <span ljsid-1=\"\">EDGE</span> Summit.":1,"#Be the first to access updates on registration, featured speakers, agenda details, and exclusive early-bird opportunities.":1,"#Momentum is building for this event.":1,"#Stay in the Know":1,"#with growth strategies led by experienced clinicians":1,"#to enhance patient outcomes":1,"#<span ljsid-1=\"\">EDGE</span> represents more than a name,<br ljsid-3=\"\"> it is a <span ljsid-5=\"\">mindset:</span>":1,"#Learn strategies":1,"#emerging diagnostic trends and technologies":1,"#Stay ahead of":1,"#leading-edge clinical education for MosaicDX Testing":1,"#Gain exclusive access to":1,"#EDGE Summit?":1,"#Attend":1,"#Why":1,"#*Exact locations to be announced shortly":1,"#Together, these deeply seasoned experts bring decades of advanced training and real-world clinical experience, guiding practitioners to master MosaicDX testing, translate data into confident clinical application, and unlock strategies that will accelerate practice growth and impact patient lives.":1,"#LET US KNOW IF YOU ARE INTERESTED":1,"#East Coast":1,"#May 14 – 16, 2026":1,"#West Coast":1,"#April 30 – May 2, 2026":1,"#Learn scalable strategies to strengthen your clinical model, expand service offerings, improve patient outcomes, and position your practice as a leader in advanced, results-driven care.":1,"#Practice Growth Guidance":1,"#Gain immediate expertise by analyzing real-world cases woven throughout all modules, ensuring powerful integration of OAT testing into your practice right away.":1,"#Real-World Case Expertise":1,"#Confidently design individualized, evidence-based interventions tailored to each patient’s unique OAT profile.":1,"#The <strong ljsid-1=\"\">EDGE</strong> Summit is a premier clinical education event designed for forward-thinking practitioners who want to stay at the forefront of diagnostics-driven, personalized care. Taking place in 2026, this immersive summit will be led by MosaicDX Chief Medical Officer, Kurt Woeller, D.O., alongside an elite clinical team of naturopathic physicians and registered dietitians.":1,"#Evidence-Based Interventions":1},"version":125015}]